Skip Nav Destination
Issues
1 January 1996
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
ISSN 0008-5472
EISSN 1538-7445
Issue Sections
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Articles
MAGE-1-specific Precursor Cytotoxic T-Lymphocytes Present among Tumor-infiltrating Lymphocytes from a Patient with Breast Cancer: Characterization and Antigen-specific Activation1
John F. Toso; Coreen Oei; Farshid Oshidari; James Tartaglia; Enzo Paoletti; H. Kim Lyerly; Sohel Talib; Kent J. Weinhold
Association of Loss of Heterozygosity on Chromosome 17p with High Platelet-derived Growth Factor α Receptor Expression in Human Malignant Gliomas1
Monica Hermanson; Keiko Funa; Jens Koopmann; David Maintz; Andreas Waha; Bengt Westermark; Carl-Henrik Heldin; Otmar D. Wiestler; David N. Louis; Andreas von Deimling; Monica Nistér
Correlations between Intrinsic Chemoresistance and HER-2/neu Gene Expression, p53 Gene Mutations, and Cell Proliferation Characteristics in Non-Small Cell Lung Cancer Cell Lines1
Chun-Ming Tsai; Kuo-Ting Chang; Li-Hua Wu; Jeou-Yuan Chen; Adi F. Gazdar; Tetsuya Mitsudomi; Mei-Hui Chen; Reury-Perng Perng
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.